Session » Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster II: Damage and Comorbidities
-
Abstract Number: 1585
Role of Corticosteroids in Subclinical Atherosclerosis in SLE: A Systematic Review and Meta-Analysis
-
Abstract Number: 1586
Resistant Hypertension Is Associated with Inflammation, Renal Function, and Increased Mortality in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1587
Mycobacterial Infection in Systemic Lupus Erythematosus: Clinical Significance and Associated Factors. Data from the Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER)
-
Abstract Number: 1588
“Neoplasia in Patients with Systemic LUPUS Erythematosus in Spain: Relesser Registry DATA”
-
Abstract Number: 1589
A Multicriteria Decision Analysis for the Development of New Systemic Lupus Erythematosus Classification Criteria
-
Abstract Number: 1590
Prolonged Antimalarial Treatment Increases the Risk for Severe Brady-Arrhythmias in Systemic Lupus Erythematosus
-
Abstract Number: 1591
Monophasic Disease Course Pattern in Systemic Lupus Erythematosus
-
Abstract Number: 1592
Antimalarial-Induced Cardiomyopathy in Systemic Lupus Erythematosus
-
Abstract Number: 1593
Development of Quality Indicator Set of Systemic Lupus Erythematosus in Japan
-
Abstract Number: 1594
Bone Turnover Markers in Adults with Systemic Lupus Erythematosus
-
Abstract Number: 1595
Prevalence and Predictors of Depression in Patients with Systemic Lupus Erythematosus: Results from the Korean Lupus Network (KORNET) Registry
-
Abstract Number: 1596
Effect of the Metabolic Syndrome on Organ Damage, Renal Function and Mortality in Patients with Systemic Lupus Erythematosus: A Longitudinal Analysis
-
Abstract Number: 1597
Arthritis and Hydroxychloroquine Are Associated with Decreased Risk of Macrophage Activation Syndrome Among Adults Hospitalized with SLE
-
Abstract Number: 1598
Shrinking Lung Syndrome in Systemic Lupus Erythematosus Patients: A Diagnosis We Should Suspect More Often
-
Abstract Number: 1599
GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada
-
Abstract Number: 1601
Hydroxychloroquine Non-Adherence Is Associated with Higher Sledai Scores in a Predominantly Hispanic Population
-
Abstract Number: 1602
Fatigue in Systemic Lupus: The Role of Disease Activity and Its Mediators
-
Abstract Number: 1603
Lupus Low Disease Activity State: Can We Relax the Definition and Still Achieve Low Risk of SLE-Related Damage?
-
Abstract Number: 1604
Validation of Remission and Lupus Low Disease Activity State As Predictors of Organ Damage in SLE
-
Abstract Number: 1605
Lupus Low Disease Activity State Protects Against Most Subtypes of Organ Damage in SLE
-
Abstract Number: 1606
Cancer in an SLE Inception Cohort: Smoking May out-Perform Tumor Markers As a Risk Predictor
-
Abstract Number: 1607
Tumor-Related Autoantibodies and Cancers in SLE: A Case-Control Study from a Single Centre
-
Abstract Number: 1608
Entheseal Involvement in Systemic Lupus Erythematosus: An Ultrasound Study
-
Abstract Number: 1609
Telomere Length and Coronary Artery Atherosclerosis in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1610
The Impact of Alcohol Use on Cardiovascular Events and Overall Mortality in Women with Systemic Lupus Erythematosus
-
Abstract Number: 1611
Increased Body Mass Index May Not be a Risk Factor for the Development of Lupus Nephritis
-
Abstract Number: 1612
Primary Respiratory Disease in Patients with Systemic Lupus Erythematosus: Data from the Spanish Rheumatology Society Lupus Registry (RELESSER) Cohort
-
Abstract Number: 1613
Natural History of Disease Activity and Damage in Patients with Cutaneous Lupus Erythematosus on Standard of Care Treatments Using Longitudinal Registries from Two Academic Dermatology Centers
-
Abstract Number: 1614
“Do You Know What I Mean?” a Tool to Understand What Lupus Patients Comprehend
-
Abstract Number: 1615
Assessment of a Cognitive Impairment Measure in Systemic Lupus Erythematosus
-
Abstract Number: 1616
Early and Late Onset Biopsy Proven Lupus Nephritis without Other Associated Autoimmune Diseases: Severity and Long-Term Outcome
-
Abstract Number: 1617
Autoimmune Diseases in Patients with Cutaneous Lupus Erythematosus
-
Abstract Number: 1618
Risk Factors for Development of Early Infectious and Non-Infectious Complications in Systemic Lupus Erythematosus Patients Undergoing Major Surgery
-
Abstract Number: 1619
The Impact of Disease Characteristics on Habitual Physical Activity and Sedentary Behavior Among Patients with Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1620
Habitual Physical Activity, Sedentary Behavior and Cardiovascular Disease Risk Burden in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1621
Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By the Automated Neuropsychological Assessment Metrics
-
Abstract Number: 1622
Associations Among Classification Criteria Items within Systemic Lupus Erythematosus
-
Abstract Number: 1623
Prevalence of Cognitive Impairment in Systemic Lupus Erythematosus Assessed By a Comprehensive Neuropsychological Battery
-
Abstract Number: 1624
SLE Disease Activity Index Glucocorticosteroid Index (SLEDAI-2KG) Identifies More Responders Than Sledai-2K
-
Abstract Number: 1625
Incidence and Outcomes of Venous Thromboembolism in Hospitalized Patients with Systemic Lupus Erythematosus: Results from Nationwide Inpatient Sample Database 2003-2011
-
Abstract Number: 1626
Childhood-Onset Predicts Increased Steroid-Related Damage Among Adults with Systemic Lupus Erythematosus
-
Abstract Number: 1627
Changes in Heart Rate Variability Reflect Changes in Clinical Status and Patient Reported Outcomes in Systemic Lupus Erythematosus: A Longitudinal Analysis
-
Abstract Number: 1628
Atrial Fibrillation/Flutter Hospitalizations Among Patients with SLE and Diabetes Compared to the General U.S. Medicaid Population
-
Abstract Number: 1629
Disease Activity Is an Independent Predictor of Leukopenia in a Large International SLE Cohort
-
Abstract Number: 1630
Achievement of Lupus Low Disease Activity State (LLDAS) in the Early Phase of Systemic Lupus Erythematosus Prevent Damage Accrual
-
Abstract Number: 1631
Hospital Readmissions for SLE in the United States: A National Database Study
-
Abstract Number: 1632
SLE Characteristics Associated with Modified Framingham Risk Score in Patients without Clinical Cardiovascular Disease
-
Abstract Number: 1633
Use of Emergency Department (ED) and Resulting Hospitalization By Patients with Systemic Lupus Erythematosus (SLE) in a Predominantly Afro-Caribbean Inner-City Cohort
-
Abstract Number: 1634
Body Mass Index and Disease Activity in Systemic Lupus Erythematosus- a Paradoxical Relationship?
-
Abstract Number: 1635
Cachexia in Systemic Lupus Erythematosus- an Underrecognized Syndrome
-
Abstract Number: 1636
Body Mass Index at Disease Onset Is Predictive of Future Organ Damage in Systemic Lupus Erythematosus
-
Abstract Number: 1637
Sexual Function in Married Indian Women with Systemic Lupus Erythematosus
-
Abstract Number: 1638
High Genetic Risk Score Is Associated with Increased Organ Damage in SLE
-
Abstract Number: 1639
Longitudinal Evolution in a Nationwide Cohort Originally Classified As Mixed Connective Tissue Disease
-
Abstract Number: 1640
SLICC Damage Index Is Associated with Tubulointerstitial Nephritis on Lupus Nephritis Biopsies
-
Abstract Number: 1641
Indications for Initial Renal Biopsy in Systemic Lupus Erythematosus: A Systematic Review of the Literature
-
Abstract Number: 1642
Role of Plaque in Predicting Cardiovascular Events in Women with Lupus over a 20 Year Followup
-
Abstract Number: 1643
15 Year Comparative Analysis of Cardiovascular Events in Female Subjects with Lupus Versus Controls
-
Abstract Number: 1644
Less Than Seven Hours of Sleep per Night Is Associated with Transitioning to Systemic Lupus Erythematosus
-
Abstract Number: 1645
Tobacco Exposure and Relationship with Severe Damage in Systemic Lupus Erythematosus Patients
-
Abstract Number: 1646
Cardiovascular disease in Systemic Lupus Erythematosus. The road to hell is paved with good intentions
-
Abstract Number: 1647
A Lupus Low Disease Activity State Is Associated with Reduced Flare, Lower Organ Damage Accrual, and Better Quality of Life in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1648
Assessment of Outcome in Lupus Nephritis Patients: A Retrospective Analysis of a Single Center Cohort over 20 Years
-
Abstract Number: 1649
Sleep Disturbances in Systemic Lupus Erythematosus (SLE)
-
Abstract Number: 1650
The Montreal Cognitive Assessment Questionnaire (MoCA): A Promising Screening Tool for Cognitive Dysfunction in SLE
-
Abstract Number: 1651
Screening in Patients at High Risk of Hydroxychloroquine Retinal Toxicity
-
Abstract Number: 1652
Trajectories of Quality of Life in an Iception Cohort of Lupus Patients and Their Determinants